Free Trial

Eli Lilly and Company (LLY) SEC Filings & 10K Form

$922.39
-1.32 (-0.14%)
(As of 02:52 PM ET)

Recent Eli Lilly and Company SEC Filings

DateFilerForm TypeView
09/12/2024
3:16 PM
Eli Lilly and Company (Issuer)
Skovronsky Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
6:03 AM
Eli Lilly and Company (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2024
3:05 PM
Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
3:47 PM
Eli Lilly and Company (Subject)
Zakrowski Donald A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
3:21 PM
Eli Lilly and Company (Issuer)
Eli Lilly and Company (Issuer)
Zakrowski Donald A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
11:54 AM
Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
3:12 PM
Alvarez Ralph (Reporting)
Eli Lilly and Company (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:14 PM
Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:15 PM
Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:17 PM
Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:18 PM
Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
7:51 AM
Eli Lilly and Company (Filed by)
Morphic Holding, Inc. (Subject)
Form SC TO-T/A
08/14/2024
11:27 AM
Eli Lilly and Company (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:31 PM
Eli Lilly and Company (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
08/13/2024
3:19 PM
Eli Lilly and Company (Issuer)
Hakim Anat (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:51 PM
Eli Lilly and Company (Subject)
Form FWP
08/12/2024
7:12 AM
Eli Lilly and Company (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
08/08/2024
10:28 AM
Eli Lilly and Company (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
6:04 AM
Eli Lilly and Company (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
5:07 AM
Eli Lilly and Company (Filed by)
Morphic Holding, Inc. (Subject)
Form SC TO-T/A
07/19/2024
3:16 PM
Brooks Gordon J. (Reporting)
Eli Lilly and Company (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/19/2024
5:09 AM
Eli Lilly and Company (Filed by)
Morphic Holding, Inc. (Subject)
Form SC TO-T
07/16/2024
3:17 PM
Alvarez Ralph (Reporting)
Eli Lilly and Company (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
3:18 PM
Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
3:20 PM
Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
3:21 PM
Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
3:22 PM
Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
12:19 PM
Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2024
7:40 AM
Eli Lilly and Company (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2024
3:00 PM
Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
6:14 AM
Eli Lilly and Company (Filed by)
Morphic Holding, Inc. (Subject)
Form SC TO-C
07/02/2024
3:00 PM
Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
1:25 PM
Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2024
3:00 PM
Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:43 PM
Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2024
3:22 PM
Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:23 PM
Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
1:49 PM
Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2024
1:03 PM
Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2024
1:23 PM
Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2024
6:48 AM
Eli Lilly and Company (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
BREAKING NEWS: AI Tech Now Used to Stop School Shooters (Ad)

Two seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a shooter's exact location.

Don't miss out. Get the full details on this AI bargain.
06/04/2024
3:14 PM
Eli Lilly and Company (Issuer)
Rau Diogo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
5:29 PM
Eli Lilly and Company (Subject)
Zakrowski Donald A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
5:30 PM
Eli Lilly and Company (Subject)
Norton Johna (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
3:14 PM
Eli Lilly and Company (Issuer)
Norton Johna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
1:32 PM
Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/24/2024
2:13 PM
Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/21/2024
3:18 PM
Alvarez Ralph (Reporting)
Eli Lilly and Company (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:19 PM
Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
2:20 PM
Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/30/2024
11:04 AM
Eli Lilly and Company (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2024
6:04 AM
Eli Lilly and Company (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
3:11 PM
Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
3:12 PM
Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
3:13 PM
Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
3:14 PM
Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2024
11:59 AM
AS YOU SOW (Filed by)
Eli Lilly and Company (Subject)
Form PX14A6G
03/28/2024
12:10 PM
Chevedden John (Filed by)
Eli Lilly and Company (Subject)
Form PX14A6G
03/28/2024
11:20 AM
Eli Lilly and Company (Subject)
Trinity Health Corp (Filed by)
Form PX14A6G
03/11/2024
3:24 PM
Eli Lilly and Company (Subject)
Zakrowski Donald A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
3:26 PM
Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
3:16 PM
Alvarez Ralph (Reporting)
Eli Lilly and Company (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
3:18 PM
Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
10:44 AM
Eli Lilly and Company (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/15/2024
2:05 PM
Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
3:43 PM
Dozier Eric (Reporting)
Eli Lilly and Company (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
3:44 PM
Eli Lilly and Company (Issuer)
White Anne E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
3:34 PM
Eli Lilly and Company (Issuer)
Hakim Anat (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
3:36 PM
Eli Lilly and Company (Issuer)
Skovronsky Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
3:23 PM
Eli Lilly and Company (Issuer)
Rau Diogo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
3:25 PM
Eli Lilly and Company (Issuer)
Jonsson Patrik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
10:56 AM
Eli Lilly and Company (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
8:26 AM
Eli Lilly and Company (Subject)
PNC FINANCIAL SERVICES GROUP, INC. (Filed by)
Form SC 13G/A
02/08/2024
2:34 PM
Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/07/2024
4:08 PM
Eli Lilly and Company (Subject)
Form FWP
02/07/2024
7:12 AM
Eli Lilly and Company (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
02/06/2024
6:04 AM
Eli Lilly and Company (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2024
3:32 PM
Eli Lilly and Company (Issuer)
Hakim Anat (Reporting)
Hakim Anat (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
3:20 PM
Eli Lilly and Company (Issuer)
White Anne E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
2:26 PM
BlackRock Inc. (Filed by)
Eli Lilly and Company (Subject)
Form SC 13G/A
01/17/2024
3:15 PM
Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
3:17 PM
Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
3:19 PM
Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
2:22 PM
Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/12/2024
3:05 PM
Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
1:15 PM
Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
2:11 PM
Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/22/2023
5:40 PM
Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
Form SC TO-T/A
12/18/2023
5:59 AM
Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
Form SC TO-T/A
12/04/2023
3:17 PM
Eli Lilly and Company (Issuer)
Zakrowski Donald A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
6:04 AM
Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
Form SC TO-T/A
BREAKING NEWS: AI Tech Now Used to Stop School Shooters (Ad)

Two seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a shooter's exact location.

Don't miss out. Get the full details on this AI bargain.
11/21/2023
3:27 PM
Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
3:29 PM
Eli Lilly and Company (Issuer)
Runge Marschall S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
3:15 PM
Baicker Katherine (Reporting)
Eli Lilly and Company (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
3:18 PM
Eli Lilly and Company (Issuer)
Fyrwald J Erik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
3:20 PM
Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
3:22 PM
Eli Lilly and Company (Issuer)
JACKSON JAMERE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
3:24 PM
Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
5:53 AM
Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
Form SC TO-T/A
11/15/2023
5:51 AM
Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
Form SC TO-T/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:LLY) was last updated on 9/16/2024 by MarketBeat.com Staff

From Our Partners